-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, TShck3agHHhqizAfNG/tQTeGgJFNJt+0XbnpYBm25vZjVW9uSP+CDWv6kC6XpFhh /Zwry96NQy2qeinWx/+Ijw== 0000950117-03-000209.txt : 20030124 0000950117-03-000209.hdr.sgml : 20030124 20030124152347 ACCESSION NUMBER: 0000950117-03-000209 CONFORMED SUBMISSION TYPE: 5 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20021231 FILED AS OF DATE: 20030124 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: PHARMACIA CORP /DE/ CENTRAL INDEX KEY: 0000067686 STANDARD INDUSTRIAL CLASSIFICATION: CHEMICALS & ALLIED PRODUCTS [2800] IRS NUMBER: 430420020 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 5 SEC ACT: 1934 Act SEC FILE NUMBER: 001-02516 FILM NUMBER: 03524082 BUSINESS ADDRESS: STREET 1: 100 ROUTE 206 NORTH CITY: PEAPACK STATE: NJ ZIP: 07977 BUSINESS PHONE: 9089018000 MAIL ADDRESS: STREET 1: 100 ROUTE 206 NORTH CITY: PEAPACK STATE: NJ ZIP: 07977 FORMER COMPANY: FORMER CONFORMED NAME: MONSANTO CHEMICAL CO DATE OF NAME CHANGE: 19711003 FORMER COMPANY: FORMER CONFORMED NAME: MONSANTO CO DATE OF NAME CHANGE: 19920703 REPORTING-OWNER: COMPANY DATA: COMPANY CONFORMED NAME: NEEDLEMAN PHILIP CENTRAL INDEX KEY: 0001083221 RELATIONSHIP: OFFICER FILING VALUES: FORM TYPE: 5 BUSINESS ADDRESS: STREET 1: C/O MONSANTO CO STREET 2: 800 NORTH LINDBERGH BLVD CITY: ST LOUIS STATE: MO ZIP: 63167 BUSINESS PHONE: 3146941000 MAIL ADDRESS: STREET 1: C/O MONSANTO CO STREET 2: 800 NORTH LINDBERGH BLVD CITY: ST LOUIS STATE: MO ZIP: 63167 5 1 a34204.htm PHILIP NEEDLEMAN
FORM 5

[__] Check box if no longer
      subject to Section 16. Form 4 or Form
      5 obligations may continue.
      See Instruction 1(b).

[__]  Form 3 Holdings Reported
[__]  Form 4 Transactions Reported

 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C.  20549

ANNUAL STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility
Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL


OMB Number: 3235-0362
Expires: January 31, 2005
Estimated average burden
hours per response. . . . 1.0
1. Name and Address of Reporting Person*
   Needleman, Philip 
(Last)                      (First)                      (Middle)

  100 Route 206 North
(Street)

  Peapack, NJ 07977
(City)                      (State)                      (Zip)
2. Issuer Name and Ticker
    or Trading Symbol

   Pharmacia - PHA
3. I.R.S. Identification
    Number of Reporting
    Person, if an entity
    (Voluntary)

     
4. Statement for
    (Month/Year)

   12/2002

5. If Amendment,
    Date of Original
    (Month/Year)

    
6. Relationship of Reporting Person(s) to Issuer
(Check all applicable)


  __   Director                                __   10% Owner

   X    Officer (give title below)        __   Other (specify below)

    Senior Executive Vice President    
7. Individual or Joint/Group Reporting
    (check applicable line)

  _ X _    Form Filed by One Reporting Person

  ____    Form Filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security
    (Instr. 3)
2. Transaction Date
    (Month/Day/Year)
2A. Deemed
      Execution
      Date,
      if any (Month/
      Day/ Year)
3. Transaction Code
    (Instr. 8)
4. Securities Acquired (A) or Disposed of (D)  
    (Instr. 3, 4 and 5)
5. Amount of
    Securities
    Beneficially
    Owned at the end of
    Issuer's Fiscal Year
    (Instr. 3 and 4)
6. Ownership
    Form:
    Direct (D)
    or Indirect (I)
    (Instr. 4)
7.   Nature of
     Indirect
     Beneficial
     Ownership
     (Instr. 4)
Amount (A) or (D) Price
Common11/13/2002 G717D 198,005D 
Common      14,731ISavings Plan

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).


Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
    (Instr. 3)
2. Conver-
    sion or
    Exercise
    Price of
    Deri-
    vative
    Security
3. Transaction
    Date  (Month/
    Day/ Year)
3A. Deemed
      Execution Date,
      if any (Month/
      Day/ Year)
4. Transaction Code     
    (Instr. 8)

5. Number of
    Derivative
    Securities
    Acquired (A)
    or Disposed of (D)
    (Instr. 3, 4 and 5)
6. Date Exercisable and
    Expiration Date
    (Month/Day/Year)
7. Title and Amount
    of  Underlying
    Securities
    (Instr. 3 and 4)
8. Price of
    Derivative
    Security
    (Instr. 5)
9. Number of
    Derivative
    Securities
    Beneficially
    Owned
    at End of
    Year
    (Instr. 4)
10. Ownership of      Derivative
     Security:
     Direct (D)
     or Indirect (I)
     (Instr. 4)
11. Nature of
      Indirect
      Beneficial
      Ownership
      (Instr. 4)
(A) (D) Date
Exercisable		 Expiration
Date		 Title Amount or
Number of
Shares
               

Explanation of Responses:   

            /s/ Don W. Schmitz, attorney-in-fact for Philip Needleman                     01/24/2003   
** Signature of Reporting Person Date


** Intentional misstatements or omissions of facts constitute Federal Criminal Violations.
        See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note:   File three copies of this Form, one of which must be manually signed. If space is insufficient,
            see Instruction 6 for procedure.
-----END PRIVACY-ENHANCED MESSAGE-----